Calypte's HIV-1 Urine Test Approved for Use in People's Republic of China

(ALAMEDA, CA) Calypte Biomedical Corporation has announced that the State Drug Administration of the People's Republic of China (PRC) has approved its HIV-1 antibody urine test. According to the Joint Nations Programme on HIV/AIDS, half a million Chinese citizens are currently infected with the HIV virus. Left unchecked, officials of the Chinese National Center for AIDS Prevention and Control (NCAIDS) estimate that the total number of HIV infections in China could reach 10 million before 2010. Earlier this year, Calypte announced that it had partnered with NCAIDS through Beijing HuaAi Science and Technology Development Co. Ltd. to distribute the HIV-1 urine test within the PRC. For more information visit www.calypte.com.